Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Ying-Yi Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6269-2992; OpenAlex author ID A5101536986. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 5

  1. Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways. Co-author DOI 10.1038/s41419-025-07495-2↗
  2. Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways. Co-author DOI 10.1038/s41419-018-0574-1↗
  3. Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. Co-author DOI 10.3892/mmr.2016.5471↗
  4. miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells. Co-author DOI 10.1007/s13277-015-3679-5↗
  5. Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor. Last author DOI 10.1016/j.jss.2013.06.004↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chen Liang · 3 shared papers, 2015–2025 · strength 0.38
  2. Hong‐Xi Xu · 2 shared papers, 2018–2025 · strength 0.32
  3. Yang Li · 2 shared papers, 2018–2025 · strength 0.32
  4. Zhen Wang · 2 shared papers, 2018–2025 · strength 0.32
  5. Hongyu Li · 2 shared papers, 2013–2015 · strength 0.10
  6. Zhouyu Ning · 1 shared paper, 2016 · strength 0.08
  7. Haiyong Wang · 1 shared paper, 2016 · strength 0.08
  8. Xiaoyan Zhu · 1 shared paper, 2016 · strength 0.08
  9. Zhiqiang Meng · 1 shared paper, 2016 · strength 0.08
  10. Fei Zhang · 1 shared paper, 2015 · strength 0.06
  11. Bin Liu · 1 shared paper, 2013 · strength 0.04
  12. Li Wu · 1 shared paper, 2013 · strength 0.04
  13. Chen Wang · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.